Regression analysis (r2) of the relationship between bropirimine metabolite formation and sample-to-sample variation in cytochrome P450 activities across a population of human livers (N = 9)
| BDH | 4′-OH | 3′-OH | 1A2 | 2C9 | 2C19 | 2D6 | 2E1 | 3A4 | |
|---|---|---|---|---|---|---|---|---|---|
| BDH | 1.00 | ||||||||
| 4′-OH | 0.19 | 1.00 | |||||||
| 3′-OH | 0.17 | 0.95 | 1.00 | ||||||
| 1A2 | 0.18 | 0.62 | 0.62 | 1.00 | |||||
| 2C9 | 0.31 | 0.19 | 0.21 | 0.05 | 1.00 | ||||
| 2C19 | 0.63 | 0.23 | 0.22 | 0.16 | 0.09 | 1.00 | |||
| 2D6 | 0.20 | 0.02 | 0.09 | 0.07 | 0.01 | 0.03 | 1.00 | ||
| 2E1 | 0.02 | 0.01 | 0.00 | 0.06 | 0.12 | 0.30 | 0.07 | 1.00 | |
| 3A4 | 0.14 | 0.09 | 0.17 | 0.19 | 0.11 | 0.24 | 0.10 | 0.07 | 1.00 |
BDH, bropirimine dihydrodiol; m-OH,m-hydroxybropirimine; and p-OH,p-hydroxybropirimine.